"Designing Growth Strategies is in our DNA"
The global contraceptive devices market size was valued at USD 7,013.8 Million in 2017, is projected to reach USD 11,166.4 Million by the end of 2025, exhibiting a CAGR of 6.0%.
In the last few decades, the increased demand is reflected by the contraceptive devices. Awareness of contraception and the presence of effective methods for prevention of conception are the major determinants of national pregnancy and birth rates.
The upsurge in the use of contraceptive devices can be attributed to robust government promotions and schemes for women and child health. Government participation in promoting family planning and contraception especially in emerging nations is a key factor associated with the growth of the global contraceptives devices market.
Request a Free sample to learn more about this report.
"Female Contraceptive Devices to Account for Highest Market Share by 2025"
Contraceptive devices are available for both male and female. Availability of a variety of female contraceptive devices and significant uptake of intrauterine devices all over the globe is propelling the sale of female contraceptive devices at an exponential rate. Female contraceptive devices segment is expected to remain dominant throughout the forecast duration. Various female contraceptive devices commercially available in the market are vaginal rings, intrauterine devices, sub-dermal implants, female condoms, diaphragms & sponges, and others.
In terms of technology, the global contraceptives devices market is categorised into hormonal contraceptives and barrier contraceptives. Hormonal contraceptives segment is estimated to lead the market in terms of revenue between 2018 & 2025, it is attributable to its rising preference and efficiency.
To know how our report can help streamline your business, Speak to Analyst
Various distribution channels in the global contraceptive devices market are hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGO, and others. Hospital pharmacy is a major source for the contraceptive devices, owing to the increased uptake of implantable contraceptive devices by healthcare professionals and active government support for distribution of contraceptives through government aided hospitals across the globe. Owing to the rising demand for contraceptives, the market is expected to grow significantly over the years to come.
"Proactive Government of Densely Populated Countries Such as China & India Focusing on Implementing the Population Control Measures is Augmenting the Market in Asia Pacific with Maximum CAGR"
North America accounted for the maximum revenue with USD 3,418.8 Mn in 2017 and is projected to continue to remain dominant during 2018-2025, which is attributable to the upsurge in the usage of male condoms in the U.S. & Canada.
However, rising public awareness about reversible contraceptive measures and government participation in implementing the population control policies in China is likely to boost the expansion of contraceptive devices market in Asia Pacific with relatively significant CAGR during the forecast period. Europe is projected to grow in terms of revenue by the end of 2025, owing to the availability of cost-effective options of contraception across the region.
North America Contraceptive Devices Market, 2017
To get more information on the regional analysis of this market, Request a Free sample
"Merck & Co. Inc. and Bayer AG to Lead the Global Contraceptive Devices Market "
The contraceptive devices market is fragmented, with numerous players operating in the manufacturing & distribution of products. In September 2016, Bayer AG received FDA approval for Kyleena, an intrauterine system for the intentional prevention of pregnancy for up to five years, proving a new birth control option for women. This is projected to propel its market share in the coming years. The market comprises of numerous local and regional players. Other key market players operating in the market are Janssen Pharmaceutical Company, Pfizer Inc., Teva Pharmaceuticals Industry, Mylan, Merck & Co. Inc., Allergan plc, Reckitt Benckiser plc, Veru Inc., Church & Dwight, Co., Inc., Medisafe Distribution Inc., etc.
Ensuring access to contraceptive devices for women is important for the health of women, to prevent early child bearing. However, according to the World Health Organization (WHO), 214 Mn women of reproductive age in developing countries who want to avoid pregnancy are not using a modern contraceptive method. Use of contraceptive devices can reduce the risk associated with women’s heath due to early childbearing, unsafe abortion, and aid in preventing sexually transmitted diseases. The improving literacy rates especially among women have encouraged rapid adoption of contraceptive devices among women.
The report provides qualitative and quantitative insights on the contraceptive devices industry and detailed analysis of market size & growth rate for all possible segments in the market. The market is segmented by product type, technology, and distribution channel. On the basis of product type, the global market is categorized into male contraceptive devices and female contraceptive devices (female condoms, diaphragms & sponges, vaginal rings, intrauterine devices, sub-dermal implants, and others).
In terms of technology, the global contraceptive devices market is classified into hormonal contraceptives and barrier contraceptives. Various distribution channels for contraceptive devices include hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGOs, and others. Geographically, the market is segmented into five major regions, which are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions are further categorized into countries.
To gain extensive insights into the market, Request for Customization
Along with this, the report provides elaborative analysis of the market dynamics and competitive landscape. Various key insights provided in the report are fertility statistics for key countries, new product launch, key technological advancements, recent industry developments such as partnerships, mergers & acquisitions, the regulatory scenario for key countries, and key industry trends.
By Product Type
· Male Contraceptive Devices
· Female Contraceptive Devices
. Female Condoms, Diaphragms & Sponges
. Vaginal Rings
. Intrauterine Devices
. Sub-dermal Implants
· Hormonal Contraceptives
· Barrier Contraceptives
By Distribution Channel
· Hospital Pharmacy
· Retail Pharmacy
· Online Channels
· Public Channel & NGO
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Based on the detailed study conducted by Fortune Business Insights, the market was valued at USD 7.01 Billon in 2017.
Fortune Business Insights has estimated the value of the market at USD 11.16 Billion in 2025.
The market is projected to grow at a CAGR of 6.0% during the forecast period (2018-2025).
The market in North America generated a revenue of USD 3.41 Billion in 2017.
Proactive initiatives by government for population control is driving the growth of global market.
Pfizer Inc., Bayer AG and Allergan are the companies that dominated the market in 2017.
Based on the analysis done by Fortune Business Insights, market players operating in the market are anticipated to witness diverse opportunities due to rising awareness among general population in emerging countries.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry